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Abstract
Ž .Nitric oxide NO has been shown to act as a mediator of cytokines in bone tissue. We have previously demonstrated that vanadium
compounds are insulin- and growth factor-mimetic compounds in osteoblasts in culture, although high doses are toxic to these cells. In
Ž .this study, we measured NO production in two osteoblast-like cells UMR106 and MC3T3E1 incubated with different concentrations
Ž .2.5–100 mM of vanadate. Vanadate induced NO release in a biphasic manner, with levels being significantly increased at concentrations
over 50 mM. The NO donor, sodium nitroprusside, mimicked the vanadate effect: it inhibited cell growth and alkaline phosphatase
Ž .activity in a dose-dependent manner. Vanadate enhanced the NO synthases, the endothelial and inducible eNOS and iNOS isoforms, in
a dose-dependent manner. Experiments performed with the ionophore A23187 and EGTA suggested that vanadate-induced NO
production involves Ca2q-dependent and -independent mechanisms. Altogether, our results suggest that NO may play a critical role in the
bioactivity of vanadium in osteoblast-like cells. q 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Vanadium is a transition element which exists in trace
Ž .amounts in foods Nriagu, 1998 . Once incorporated into
the organism, vanadium is mainly stored in bone and
Ž .kidney Etcheverry and Cortizo, 1998 . Almost 20 years
ago, it was discovered that vanadate exhibits insulin-
mimetic actions, being hypoglycemic in animal models of
Ždiabetes and in types 1 and 2 diabetic patients Shechter,
.1990 . Actually, clinical trials are in progress in order to
Ž .assess the therapeutic application of vanadium IV in the
Žtreatment of this disease Goldfine et al., 1995; Cohen et
.al., 1995; Halberstam et al., 1996; Cusi et al., 1997 .
However, some toxic effects after the chronic use of
Žthese agents have also been reported Domingo, 1996;
.Sabbioni et al., 1993 . Using a model of osteoblast-like
cells in culture, we have previously described that com-
Ž . Ž .pounds of vanadium IV and V act, at low concentra-
Žtions, as insulin and growth factor mimetics Cortizo and
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Etcheverry, 1995; Etcheverry et al., 1997; Barrio et al.,
.1997; Salice et al., 1999 . Nevertheless, high concentra-´
tions of different vanadium derivatives induce inhibition of
growth, osteoblast differentiation and morphological trans-
formation of osteoblasts in culture. Most evidence points
toward the ability of vanadium compounds to enhance the
Žphosphorylation of protein tyrosine Gresser and Tracey,
.1990 . Consequently, an increase in phosphotyrosine pro-
tein levels could transduce vanadium signaling, leading to
its biological effects. However, additional mechanisms
may participate in the action of vanadium in bone.
Ž .Recently, the importance of nitric oxide NO as a
signaling molecule involved in bone turnover, both in vivo
Žand in vitro, has been reported Ralston, 1997; Danziger et
al., 1997; Van’t Hof and Ralston, 1997; Damoulis and
Hauschka, 1997; McCarthy et al., 1997; Hikiji et al., 1997;
.Chae et al., 1997 . NO acts as a mediator of several
stimuli, such as cytokines, mechanical stretch and sexual
hormones in bone cells. It has also been suggested that NO
exerts biphasic effects on bone-related cells: high concen-
trations inhibit osteoclast-mediated bone resorption, as well
as the growth and differentiation of osteoblasts, and low
concentrations potentiate cytokine-induced bone resorption
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and may regulate normal osteoblast growth. In addition,
immunohistochemistry and reverse transcription poly-
Ž .merase chain reaction RTrPCR experiments indicate that
Ž .mainly endothelial eNOS and inducible NO synthases
Ž . ŽiNOS are expressed in osteoblast-like cells Ralston et
al., 1994; Helfrich et al., 1997; Armour and Ralston, 1998;
Fox and Chow, 1998; Togari et al., 1998; Hukkanen et al.,
.1999 .
The purpose of the present study was to examine
Ž .whether 1 vanadate regulates NO release into culture
Ž .medium, 2 NO actively affects osteoblast growth and
differentiation, using alkaline phosphatase activity as a
Ž .marker, and 3 eNOS and iNOS protein expression is
altered by vanadate in two osteoblast-like cells in culture.
2. Material and methods
2.1. Materials
Ž .Sodium orthovanadate V was obtained from Sigma.
ŽTissue culture material was provided by Corning Prince-
. Ž .ton, NJ . Dulbecco’s Modified Eagles Medium DMEM
Žand trypsin-EDTA were supplied by Gibco Gaithersburg,
. Ž .MD and fetal bovine serum was from Gen Argentina .
Ž .Polyclonal endothelial and inducible NO synthase NOS
antibodies were from Research Biochemicals International
Ž .RBI; MA, USA . All other chemicals and reagents were
obtained from commercial sources and were of analytical
grade.
2.2. Cell culture and incubations
MC3T3E1 osteoblastic mouse calvaria-derived cells and
UMR106 rat osteosarcoma-derived cells were grown in
75-cm2 flasks at 378C in a humidified 5% CO atmo-2
sphere in DMEM supplemented with 100 Urml penicillin,
Ž .100 mgrml streptomycin and 10% vrv fetal bovine
serum. When 70–80% confluence was reached, cells were
subcultured using 0.1% trypsin — 1 mM EDTA in Caq2
q2 Ž . Ž— Mg -free phosphate-buffered saline PBS Cortizo
.and Etcheverry, 1995; Etcheverry et al., 1997 . For experi-
ments, cells were seeded in six- or twenty-four-well plates
at a density of 2.5=104 cellsrwell. When cells reached
confluence, the medium was replaced with serum- and
phenol red-free DMEM and cells were incubated with
Ždifferent concentrations of vanadate or medium alone basal
. Ž .condition , with or without other agents EGTA, A23187
for 24 h. At the end of this incubation period, the culture
medium was collected, cells were removed by centrifuga-
tion, and the nitrite level was evaluated as described
below. The cell monolayer was washed with PBS and
extracted with 0.1% Triton-X100. The cell protein content
Ž .was assayed by the Bradford method Bradford, 1976 .
Osteoblast differentiation was assessed by measuring alka-
line phosphatase activity as a marker of the osteoblast
Ž .phenotype Stein and Lian, 1993 , as previously described
Ž .Cortizo and Etcheverry, 1995 . Briefly, the enzyme activ-
ity was assayed by the hydrolysis of p-nitrophenyl phos-
phate to p-nitrophenol at 378C in glycine buffer pH 10.5
and absorbance at 405 nm was measured.
In another series of experiments, cells were incubated
with different concentrations of the NO donor sodium
nitroprusside, and cell proliferation and alkaline phos-
phatase activity were evaluated. Alternatively, cells were
Žlysed in Laemmli buffer under reducing conditions Laem-
.mli, 1970 , in order to evaluate NOS protein by Western
blot as described below.
2.3. Cell proliferation. Crystal Õiolet bioassay
The growth of osteoblast-like cells was determined by
Ž .the crystal violet bioassay Okajima et al., 1992 . Briefly,
cells were washed with PBS and fixed with 5% glutaralde-
hyde for 10 min. Then, they were stained with 0.5%
crystal violetr25% methanol for 10 min. After that, the
excess dye was discarded and the plate was washed with
water and dried. The dye taken up by the viable cells was
extracted using 0.1 M glycinerHCl buffer, pH 3.0r30%
methanol and transferred to test tubes. Absorbance was
read at 540 nm after a convenient dilution. We have
previously shown that, under these conditions, the colori-
metric bioassay results strongly correlate with the number
of viable cells measured by cell counting after staining
Žwith Trypan blue in a Neubauer chamber rs0.90, P-
0.001; rs0.97, P-0.001; for UMR and MC3T3E1 cells,
respectively; Cortizo and Etcheverry, 1995; Salice et al.,´
.1999 .
2.4. NO production
NO production was assessed by measuring the stable
end product of NO, nitrite, in the culture medium using the
Ž .Griess reaction Green and Wagner, 1982 . Briefly, 400-ml
Žsamples of conditioned media or nitrite standards 0–100
. ŽmM were mixed with 400 ml of Griess reagent 1%
sulfanilamide and 0.1% naphthylethylene-diamine in 5%
.phosphoric acid , and absorbance was measured at 530 nm
against a blank prepared with non-conditioned medium.
2.5. Western blot analysis of NOS protein
The protein content in the cell lysates was evaluated by
Ž .the method of Lowry et al. 1951 . The lysate was heated
at 1008C for 3 min and 15 mg of protein was subjected to
8% sodium dodecyl sulfate polyacrylamide gel elec-
trophoresis. The separated proteins were then transferred to
nitrocellulose membranes. To control loading and transfer,
the membranes were reversibly stained with 0.2% Ponceau
ŽS in 3% trichloroacetic acid before blocking Docena et
.al., 1999 . After washing with water, the membranes were
blocked in 3% non-fat dry milk in Tris-buffered saline
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Ž .TBS for 2 h at room temperature and incubated with
anti-iNOS or eNOS polyclonal antibodies in 0.5% bovine
Ž .serum albumin in PBS 1:2000 at 48C for 24 h. After four
washes with TBS, the membranes were incubated with a
secondary goat anti-rabbit antibody, followed by staining
with the avidinralkaline phosphatase-biotin reagent and
nitroblue tetrazolium — 5-bromo-4-chloro-3-indolyl phos-
Ž .phate NBT-BCIP from the Vectastin kit. The intensity of
the iNOS or eNOS specific bands was quantified by
densitometry after scanning of nitrocellulose paper using a
Hewlett-Packard Scanjet 4C and images were analyzed
using the Scion-beta 2 program.
2.6. Statistical analysis
Studenst’s t-test was used for comparisons between
basal and experimental groups. All results are expressed as
means"S.E.M. and represent at least three different ex-
periments.
3. Results
3.1. Effect of Õanadate on osteoblast growth and differenti-
ation
As we have previously described, vanadate regulated
Žosteoblast growth in a biphasic manner Etcheverry and
.Cortizo, 1998 . It stimulated cell proliferation at 2.5 mM in
MC3T3E1 and 2.5–50 mM in UMR106 cells, but inhibited
Ž .cell growth at higher concentrations Table 1 . The greatest
vanadate-induced inhibition of cell growth was observed
with the MC3T3E1 non-transformed osteoblast-like cells,
which suggests a great sensitivity of this cell line to
vanadate. In addition, vanadate inhibited osteoblast differ-
entiation in a dose-related manner, as evaluated by the
alkaline phosphatase specific activity in the UMR106 cells,
Table 1
Effects of vanadate on osteoblast-like cell proliferation and differentiation
Vanadate MC3T3E1 UMR106 Alkaline
Ž .mM cell number cell number phosphatase
Ž . Ž . Ž .% basal % basal % basal
0 100"3 100"5 100"6
)) ))2.5 119"4 105"4 70"5
))) ) )))10 75"5 116"5 57"9
))) ) )))25 62"6 117"6 42"5
))) )))50 54"1 109"5 41"7
))) ) )))100 33"6 85"3 43"11
Ž .Numbers are expressed as % basal and represent means"S.E.M. ns9 .
4 Ž . 4Basal values are 1.3=10 cellsrml MC3T3E1 , 2.7=10 cellsrml
Ž .UMR106 for proliferation and 132 nmol p-nitrophenolrminrmg pro-
Ž .tein for alkaline phosphatase activity UMR106 cells .
) Ž .Differences vs. basal 0 mM vanadate : P-0.05.
)) Ž .Differences vs. basal 0 mM vanadate : P-0.002.
))) Ž .Differences vs. basal 0 mM vanadate : P-0.001.
Fig. 1. Effect of vanadate on nitrite production by osteoblast-like cells.
Cells were incubated for 24 h with different vanadate concentrations. The
accumulation of NO was assayed by the Griess reaction and calculated as
Ž .nmol nitritermg protein and is expressed as % basal without vanadate .
Basal values are 6.8"0.5 and 7.2"0.4 nmolrmg protein for MC3T3E1
Ž .and UMR106 cells, respectively. Values are means"S.E.M. ns8 .
Differences vs. basal are: aP-0.05, )P-0.01, ))P-0.001.
the inhibition being statistically significant at 2.5 mM
Ž .Table 1 .
3.2. Effect of Õanadate on NO production by osteoblast-like
cells
UMR106 and MC3T3E1 cells were treated with differ-
ent doses of vanadate for 24 h and the NO released into
the culture medium was measured. Fig. 1 shows that
vanadate caused NO production in a biphasic manner. At
Žlow concentrations 5 and 10 mM for MC3T3E1 and 5–25
.mM for UMR cells , a slight decrease was observed in
both osteoblast lines, although it was only statistically
significant in the case of the UMR106 cells. Increasing the
vanadate concentration in the medium induced an increase
in the NO production, which was statistically significant at
50–100 mM for MC3T3E1 and 100 mM for the UMR106
osteoblast-like cells. These results suggest that the highest
amounts of NO are released in response to high concentra-
tions of vanadate, in parallel with the vanadate-induced
inhibition of cell growth. Fig. 1 also shows that the
non-transformed MC3T3E1 cells were more sensitive to
the vanadate-stimulated NO accumulation in the culture
medium than were the osteosarcoma UMR106 cells.
3.3. Effect of sodium nitroprusside on osteoblast growth
and differentiation
To investigate the direct effect of NO on osteoblast-like
cell progression, we used sodium nitroprusside, an NO-re-
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leasing agent, with both osteoblast lines. Fig. 2A shows
that sodium nitroprusside inhibited cell number in a dose-
Ž .related manner. Apparent inhibition K values was 30i
and 350 mM for MC3T3E1 and UMR106 cells, respec-
tively. The inhibitory action of sodium nitroprusside was
stronger on the MC3T3E1 cells than on the UMR106 cells.
In the latter, a slight but not significant stimulation of cell
Ž .Fig. 2. A Effect of sodium nitroprusside on osteoblast proliferation.
Cells were incubated in serum-free medium with different concentrations
of sodium nitroprusside for 24 h. Cell proliferation was evaluated by the
crystal violet bioassay as described in Section 2 and expressed as % basal
Ž . 4 4without vanadate . Basal values are 5.7"0.2=10 and 3.9"0.05=10
cell numberrml for MC3T3E1 and UMR106 cells, respectively. Values
Ž . Ž .are means"S.E.M. ns8 . B Effect of sodium nitroprusside on os-
teoblast differentiation. Cells were incubated with sodium nitroprusside at
the doses indicated in the figure. Alkaline phosphatase activity was
evaluated as a specific marker of osteoblast differentiation and is ex-
Ž .pressed as % basal without vanadate . Basal value is 160"33 nmolrmin
Ž .mg protein. Values are means"S.E.M. ns6 .
Fig. 3. Expression of NOS protein during the induction of NO by
vanadate. MC3T3E1 osteoblast-like cells were treated with different
doses of vanadate for 24 h. Treated cells were lysed in Laemmli buffer
Ž .and electrophoresed under reducing conditions on an 8% SDS-PAGE. A
Western blot was assayed using specific rabbit polyclonal antibody
against eNOS or iNOS. A representative blot from three independent
Ž .experiments is presented. B Images were scanned and analyzed by the
Scion-beta 2 program. The relative intensity of each band is presented as
Ž .% basal condition without vanadate as a function of the vanadate
Ž .concentration and represents the means"S.E.M. ns3 .
growth was consistently observed at 50 mM sodium nitro-
prusside. These results also suggest a stronger sensitivity
of MC3T3E1 cells than UMR106 cells to NO-induced cell
arrest.
In addition, the effect of NO on osteoblast differentia-
tion was evaluated in the UMR106 cells by assaying
alkaline phosphatase specific activity. It can be seen in the
Table 2
Effect of the Ca2q ionophore A23187 on basal and vanadate-modulated
NO production and MC3T3E1 osteoblast growth
Treatment Cell number NO production
Ž . Ž .% basal % basal
Control 100"2 100"8
) )q50 mM Vanadate 50"2 176"4
) )q100 mM Vanadate 44"1 219"11
) )1 mM A23187 56"4 157"4
) )q50 mM Vanadate 8"0.6 901"45
) )q100 mM Vanadate 8"0.4 1180"90
Results are expressed as % basal and represent the means"S.E.M.
Ž . 4ns6 . Basal values are 5.1=10 cellsrml for osteoblast growth and
4.4 nmol nitritermg protein for NO production.
)Differences vs. control: P-0.001.
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Table 3
Effect of the calcium chelator EGTA on basal and vanadate-modulated
NO production and UMR106 osteoblast growth
Treatment Cell number NO production
Ž . Ž .% basal % basal
Control 100"2 100"2
))q75 mM Vanadate 94"2 125"3
) ))q100 mM Vanadate 81"5 151"6
1 mM EGTA 100"2 104"4
) )q75 mM Vanadate 92"1 117"3
) ))q100 mM Vanadate 80"3 139"5
Results are expressed as % basal and represent the means"S.E.M.
Ž . 4ns6 . Basal values are 3.7=10 cellsrml for osteoblast growth and
5.4 nmol nitritermg protein for NO production.
)Differences vs. control: P-0.01
))Differences vs. control: P-0.001.
Fig. 2B that sodium nitroprusside inhibited alkaline phos-
phatase activity in a concentration-dependent manner, with
an apparent K of 130 mM.i
3.4. Effect of Õanadate on endothelial and inducible NO
synthase protein expression
We performed Western blot analysis to further evaluate
the effect of vanadate on the protein expression of the two
major forms of NOS described in osteoblastic cells. West-
ern blot with anti-endothelial NOS antibody revealed a
band corresponding to a relative molecular mass of 135
Ž .kDa Fig. 3A . This band was increased after incubation
with 10–100 mM vanadate in the culture medium of the
Ž .MC3T3E1 cells Fig. 3B . In addition, by using an anti-in-
Žducible NOS antibody, we could detect a protein 130
.kDa , whose expression was enhanced to some extent by
Ž .75–100 mM vanadate Fig. 3A and B . These results
suggest that low concentrations of vanadate predominantly
enhance eNOS expression, while doses over 75 mM also
stimulate the inducible form of NOS in osteoblasts in
culture.
3.5. Effect of altering extra- and intracellular Ca2q leÕels
on osteoblastic cells
Experiments were performed to characterize the Ca2q
dependence of cellular NO production, under either basal
or vanadate-stimulated conditions. To increase intracellular
Ca2q levels, the MC3T3E1 cells were exposed to the Ca2q
ionophore A23187. After a 24-h incubation with A23187
alone, an inhibition of cell growth was observed; this
effect was in parallel with a 57% increase in NO produc-
Ž .tion Table 2 . Moreover, A23187 significantly potentiated
Ž .P-0.001 the vanadate-induced cytotoxicity and NO
Ž .release Table 2 . A similar effect was observed when
UMR106 osteosarcoma cells were cultured with 1 mM
A23187, under basal conditions or after vanadate incuba-
Ž .tion data not shown .
The effect of sequestration of extracellular Ca2q was
investigated and the results are shown in Table 3. In
unstimulated UMR106 cells, 1 mM EGTA did not affect
cell growth or NO production, suggesting that most of the
basal NO production was Ca2q independent. However, the
vanadate-induced NO production, but not the cytotoxicity,
was partially blocked after EGTA treatment. In contrast,
the vanadate-induced NO production and cytotoxicity were
not affected by EGTA treatment in the MC3T3E1 cells
Ž .data not shown . These results seem to indicate that the
effect of high doses of vanadate could be independent of
extracellular Ca2q.
4. Discussion
The results of our experiments demonstrate that incuba-
tion of osteoblast-like cells with vanadate leads to a bipha-
sic concentration-dependent increase in NO formation. This
effect involved two isoforms of NOS, eNOS and iNOS,
present in the osteoblasts. In addition, we partially charac-
terized the eNOS mediated-NO production by its Ca2q
dependence.
In these studies, we used two osteoblast-like cells to
investigate the mechanism by which vanadate could medi-
Žate its effects. As we previously reported Cortizo and
.Etcheverry, 1995; Barrio et al., 1997; Salice et al., 1999 ,´
Žvanadate induced a biphasic effect in both cell lines Table
.1 : low concentrations stimulated, while high doses inhib-
ited cell growth and differentiation. In addition, the non-
transformed MC3T3E1 line was more sensitive to vana-
date toxicity than was the osteosarcoma UMR106 cell line.
Cells of the latter cell line express high levels of alkaline
phosphatase activity and have a more differentiated os-
teoblast phenotype. In contrast, MC3T3E1 cells produce
low or undetectable amounts of alkaline phosphatase, but
Ž .they synthesize collagen type I Sudo et al., 1983 .
The effects of vanadate on cell growth were in parallel
Ž .with the release of NO Fig. 1 . In our cultures, the basal
production of NO by both osteoblastic cells was similar
and in the order of 1 mM or 10 nmolrmg protein. This
low level of NO is in the range previously reported by
Žother authors in osteoblastic cells Van’t Hof and Ralston,
.1997; Hikiji et al., 1997; Damoulis and Hauschka, 1997 .
Ž .However, high concentrations of vanadate )50 mM
significantly enhanced NO secretion. This response was
Ž .more pronounced in the MC3T3E1 cells Fig. 1 . To our
knowledge, this is the first report showing a direct effect of
vanadate on NO production by osteoblast-like cells. Only
two reports have suggested that vanadate could mediate its
effect by the NO pathway. For instance, Nakaike et
Ž .al. 1996 showed that the vanadate-induced relaxation of
endothelium was abolished by Nv-nitro-L-arginine meth-
ylester and pertussis toxin, although they did not measure
NO production or the expression of eNOS. However, their
( )A.M. Cortizo et al.rEuropean Journal of Pharmacology 400 2000 279–285284
results could indicate that the NO pathway is involved in
the effects of vanadate. In addition, in bone marrow-de-
Ž .rived macrophages, Shishodia et al. 1997 showed that
pre-treatment with 10 mM vanadate enhanced cytokine-in-
duced NO production and cytotoxicity. In our osteoblast
Žcultures, IL-1 plus LPS stimulated NO production data
.not shown ; however, this effect was not enhanced by the
Ž .addition of 50 mM vanadate unpublished results . Thus,
our results suggest that the bioactivity of vanadate on
osteoblasts could be mediated by the NO released in the
medium.
This hypothesis is also supported by the results obtained
Ž .by using the NO donor, sodium nitropruside Fig. 2A .
This agent slightly stimulated UMR106 proliferation; how-
ever, high concentrations were cytotoxic to the osteoblast-
like cells. In addition, sodium nitropruside was a strong
Ž .inhibitor of osteoblast differentiation Fig. 2B . The effect
of NO donors on osteoblast growth has been previously
shown, although the results for osteoblast differentiation
Ž .are controversial. Damoulis and Hauschka 1997 , using
MC3T3E1 osteoblasts, demonstrated the cytotoxic effect
Ž .of sodium nitropruside. Danziger et al. 1997 also showed
that the NO-releasing agent 3-morpholino sydnonimine
Ž .SIN-1 inhibited human primary cultures of osteoblasts in
a concentration-dependent manner: the effect was detected
at 1 and 10 mM SIN-1. Moreover, they demonstrated that
cultures exposed to SIN-1 also displayed a decreased
production of both alkaline phosphatase and osteocalcin. In
Ž .contrast, Hikiji et al. 1997 found that low concentrations
Ž y8 .of sodium nitropruside 10 M for 5 h dose-dependently
elevated alkaline phosphatase in primary cultures of mouse
osteoblasts. They suggest that NO directly facilitates os-
teoblast differentiation. The different results could be due
to a different experimental protocol or a different sensitiv-
ity of the osteoblastic cells used. In contrast, our results
confirm the previous observation that exogenous NO is
cytotoxic to osteoblasts and can mimic the effect of vana-
date.
In order to further investigate the role of the NO
pathway in the effect of vanadate, we tried to characterize
the NOS involved in its effects. Previous observations
revealed that two major isoforms of NOS are expressed in
osteoblastic cells, namely, eNOS and iNOS. The endothe-
lial constitutive NOS is expressed in osteoblasts and can
Ž .be upregulated by estrogen Armour and Ralston, 1998 .
eNOS was also detected by Western blot in MC3T3E1
Ž .cells Fig. 3A and its expression was enhanced by low
Ž .concentrations of vanadate )10 mM; Fig. 3B . Low
expression of iNOS was also detected in osteoblasts under
basal conditions, and this expression was stimulated by
Ž .high concentrations of vanadate over 75 mM . These
observations suggest that the two isoforms of NOS are
involved in the NO-release induced by vanadate in os-
teoblast-like cells.
In addition, vanadate-induced NO production was par-
2q Ž .tially inhibited by the Ca chelator EGTA Table 3 . This
effect was abolished by increasing the vanadate concentra-
tion, suggesting that a Ca2q-independent mechanism is
also involved. Moreover, NO formation was increased in
osteoblastic cells in the presence of the Ca2q ionophore
Ž .A23187 Table 2 . This ionophore also enhanced the vana-
date-induced NO content after a 24-h incubation. Alto-
gether, our results suggest that Ca2q-dependent and -inde-
pendent mechanisms participate in vanadate-induced NO
production, involving eNOS and iNOS isoforms.
In summary, vanadate induced NO production in a
biphasic dose-dependent manner. The NOS responsible
appeared to be both a Ca2q-dependent eNOS and a Ca2q-
independent iNOS. High levels of either endogenous or
exogenous NO seem to be cytotoxic to osteoblasts. In
addition, the expression of eNOS induced by low concen-
trations of vanadate could play a role in the mitogenic
effects of vanadate on osteoblast growth.
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